Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with prostate cancer (a specific type called adenocarcinoma), confirmed by a biopsy, at any stage or grade
- People who have been prescribed or are already receiving continuous hormone therapy (to reduce testosterone) for less than 5 years
- People whose blood count (haemoglobin) is above a certain level, showing they are not significantly anaemic
- People whose kidney and liver function tests are within an acceptable range, based on blood tests taken within the past 6 months
- People who are able to walk at least 100 metres (around 200 steps) without assistance, or who have a low score on a standard fitness scale used by doctors (confirm with trial site)
- People who have no medical reasons preventing them from taking part, including doing aerobic exercise
- People who are able to read, write, and understand English
- People who are willing and able to sign a formal consent form after understanding that this is a research study
Who may not be able to join:
- People with a known serious lung condition (such as severe COPD), significant heart disease, heart failure, or serious irregular heartbeat
- People with significant physical conditions affecting their bones, muscles, or joints, or significant psychological conditions that would limit participation (assessed by a doctor)
- People who are considered generally medically frail, as judged by a doctor
- People with a condition that makes it unsafe to have extra blood samples taken beyond what is normally done in routine care
- People who are unwilling or unable to follow the requirements of the study
- People whom the study investigator considers unsuitable for any other medical reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ellis Levine, MD, Roswell Park Cancer Institute
Phone: 716-845-3159
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in body composition
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.